The Skeleton and the Skin
What Nigeria's capital funding collapse means for African healthtech, and why the companies filling the gap are building a private healthcare system from the ground up.
The "PR Gap" in Medicine: Why Your Social Media "Breakthrough" Isn't a Cure (Yet)
We are living in an era of viral science. But as funding dries up and
You Can't Disrupt What Hasn't Been Built Yet
The Infrastructure Thesis · Part 1
Why "Tech Plus Assets" Is the Real Healthtech
Isolation Doesn’t Announce Itself
How isolation disguised as focus almost burned me out
Peeling Back Complexity: How We’re Simplifying African Healthcare Regulation, One Layer at a Time
The barriers to access weren’t always about innovation or cost — they were often about regulatory complexity.
Why I’m Running for HFN Publicity Secretary: A Personal Journey of Passion, Advocacy, and Impact
“My journey in healthcare has been shaped by personal experiences, professional advocacy, and an unwavering
Bioequivalence Studies in Nigeria: A New Era for Pharmaceutical Regulation
How NAFDAC’s new bioequivalence requirements will transform drug quality and reshape Nigeria’s pharmaceutical future